Senseonics Holdings, Inc. Reports Second Quarter Financial Results GlobeNewswire August 06, 2025 Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on […]
ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 06, 2025 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of
Crane NXT Reports Second Quarter 2025 Results Delivers sales growth of 9%; Maintains full year EPS guidance of $4.00 to $4.30 GlobeNewswire August 06, 2025 WALTHAM, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Crane NXT, Co. (NYSE: CXT) (“Crane NXT” or the “Company”), a premier industrial technology company, today announced its financial results for the
(NASDAQ:SWIM), LATHAM, N.Y., Aug. 06, 2025 (GLOBE NEWSWIRE) — Latham Group, Inc. (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences: On August 13, 2025, Scott Rajeski, President and Chief Executive Officer, and Oliver Gloe,
Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference GlobeNewswire August 06, 2025 BURLINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company” or “Fractyl”), a metabolic therapeutics company focused on pattern breaking approaches
Neumora Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 06, 2025 Initiated Phase 1 single-ascending dose/multiple-ascending dose (SAD/MAD) study with M4 positive allosteric modulator (PAM) NMRA-861, with data expected in the first quarter of 2026 Announces prioritization of obesity as lead indication for NMRA-215, a highly brain-penetrant NLRP3 inhibitor, with
Latham Group, Inc. to Participate at Upcoming Conferences in August 2025 GlobeNewswire August 06, 2025 LATHAM, N.Y., Aug. 06, 2025 (GLOBE NEWSWIRE) — Latham Group, Inc. (NASDAQ:SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced that management will attend the following investor conferences:
Potbelly Corporation Reports Results for Second Fiscal Quarter 2025 GlobeNewswire August 06, 2025 Second quarter system-wide sales growth of 6.7% including 3.2% company-operated same-store sales growth and positive traffic growth Eight shop openings and 54 additional franchise shop commitments in the second quarter Raises full-year guidance and introduces 3Q'25 guidance including positive same-store sales of
The Honest Company Reports Second Quarter 2025 Results GlobeNewswire August 06, 2025 Transformation Pillars Continue to Drive Profitability Improvement, Gross Margin Expansion and Revenue GrowthDelivers Net Income of $4 Million and Gross Margin of 40.4%, Expansion of 210 Basis PointsReaffirms Full Year 2025 Financial Outlook LOS ANGELES, Aug. 06, 2025 (GLOBE NEWSWIRE) — The Honest
Amplify Energy Announces Strategic Initiatives Update, Second Quarter 2025 Results, and Updated Full-Year 2025 Guidance GlobeNewswire August 06, 2025 HOUSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Amplify Energy Corp. (NYSE: AMPY) (“Amplify,” the “Company,” “us,” or “our”) announced today an update on its strategic initiatives, operating and financial results for the second quarter of 2025,